☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pompe disease
Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease
July 28, 2021
Sanofi's Avalglucosidase alfa Receives US FDA's Priority Review as Enzyme Replacement Therapy for Pompe Disease
November 18, 2020
Sanofi Report Results of Avalglucosidase alfa in P-III COMET Study for Late Onset Pompe Disease
June 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.